{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:06:33Z","timestamp":1761541593364,"version":"build-2065373602"},"reference-count":116,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010258","name":"Marfan Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000222","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000222","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.niox.2021.08.006","type":"journal-article","created":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T02:13:38Z","timestamp":1630376018000},"page":"27-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Nitric oxide in the Marfan vasculature: Friend or foe?"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7565-8507","authenticated-orcid":false,"given":"Arash Y.","family":"Tehrani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Ciufolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Bernatchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2021.08.006_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1146\/annurev.med.51.1.481","article-title":"The Marfan syndrome","volume":"51","author":"Pyeritz","year":"2000","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib2","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan's syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2021.08.006_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/hmg\/2.7.961","article-title":"Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome","volume":"2","author":"Pereira","year":"1993","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.niox.2021.08.006_bib4","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","article-title":"Pediatric heart network investigators, I. Pediatric heart network, atenolol versus losartan in children and young adults with marfan's syndrome","volume":"371","author":"Lacro","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011103.pub2","article-title":"Beta-blockers for preventing aortic dissection in Marfan syndrome","author":"Koo","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.niox.2021.08.006_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijcard.2016.04.186","article-title":"The effect of losartan on progressive aortic dilatation in patients with Marfan's syndrome: a meta-analysis of prospective randomized clinical trials","volume":"217","author":"Gao","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib7","article-title":"Role of losartan in prevention of aortic dilatation in Marfan syndrome: a systematic review and meta-analysis","author":"Li","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib8","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2021.08.006_bib9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0046-8177(83)80303-7","article-title":"The morphology of ascending aortic aneurysms","volume":"14","author":"Klima","year":"1983","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.niox.2021.08.006_bib10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/01.CIR.79.4.854","article-title":"Arterial hemodynamic indexes in Marfan's syndrome","volume":"79","author":"Yin","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2021.08.006_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0735-1097(10)80218-9","article-title":"The Marfan syndrome: abnormal aortic elastic properties","volume":"18","author":"Hirata","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib12","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.amjcard.2005.06.080","article-title":"Echocardiographic Doppler assessment of the biophysical properties of the aorta in pediatric patients with the Marfan syndrome","volume":"96","author":"Bradley","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14779072.2019.1704625","article-title":"Features of Marfan syndrome not listed in the Ghent nosology - the dark side of the disease","volume":"17","author":"von Kodolitsch","year":"2019","journal-title":"Expert Rev. Cardiovasc Ther."},{"key":"10.1016\/j.niox.2021.08.006_bib14","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1016\/j.jacc.2021.04.054","article-title":"Aortic branch aneurysms and vascular risk in patients with marfan syndrome","volume":"77","author":"Lopez-Sainz","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vph.2009.10.005","article-title":"Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress","volume":"52","author":"Yang","year":"2010","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.niox.2021.08.006_bib16","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/jcmm.14921","article-title":"Divergent effects of canonical and non-canonical TGF-\u03b2 signalling on mixed contractile-synthetic smooth muscle cell phenotype in human Marfan syndrome aortic root aneurysms","volume":"24","author":"Pedroza","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib17","doi-asserted-by":"crossref","DOI":"10.1152\/japplphysiol.00132.2017","article-title":"Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm","volume":"123","author":"Gibson","year":"2017","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.niox.2021.08.006_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/308645a0","article-title":"The nature of endothelium-derived vascular relaxant factor","volume":"308","author":"Griffith","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.niox.2021.08.006_bib19","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1073\/pnas.88.11.4651","article-title":"Nitric oxide: an endogenous modulator of leukocyte adhesion","volume":"88","author":"Kubes","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.niox.2021.08.006_bib20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2174\/1566524043359908","article-title":"The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all?","volume":"4","author":"Suschek","year":"2004","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib21","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nrcardio.2010.30","article-title":"Marfan syndrome. Part 1: pathophysiology and diagnosis","volume":"7","author":"Ca\u00f1adas","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib22","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.CIR.99.7.909","article-title":"Endothelial function in Marfan syndrome: selective impairment of flow-mediated vasodilation","volume":"99","author":"Wilson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2021.08.006_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/760694","article-title":"Analysis of oxidative stress enzymes and structural and functional proteins on human aortic tissue from different aortopathies","volume":"2014","author":"Soto","year":"2014","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.niox.2021.08.006_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.ijcard.2010.04.077","article-title":"Evidence for oxidative stress in plasma of patients with Marfan syndrome","volume":"145","author":"Fiorillo","year":"2010","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijcard.2015.03.423","article-title":"Molecular pathogenesis of Marfan syndrome","volume":"187","author":"Ramachandra","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/01.RES.0000191538.76771.66","article-title":"Nitric oxide regulates transforming growth factor-beta signaling in endothelial cells","volume":"97","author":"Saura","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2021.08.006_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.bbamcr.2013.12.006","article-title":"Nitric oxide-matrix metaloproteinase-9 interactions: biological and pharmacological significance NO and MMP-9 interactions","volume":"1843","author":"O'Sullivan","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.niox.2021.08.006_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajpath.2017.11.006","article-title":"Inhibition of marfan syndrome aortic root dilation by losartan: role of angiotensin II receptor type 1-independent activation of endothelial function","volume":"188","author":"Sellers","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.niox.2021.08.006_bib29","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.4266","article-title":"Nitric oxide mediates aortic disease in mice deficient in the metalloprotease Adamts1 and in a mouse model of Marfan syndrome","volume":"23","author":"Oller","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.12945\/j.aorta.2014.14-032","article-title":"Heterogeneity in the segmental development of the aortic tree: impact on management of genetically triggered aortic aneurysms","volume":"2","author":"Sherif","year":"2014","journal-title":"Aorta (Stamford, Conn.)"},{"key":"10.1016\/j.niox.2021.08.006_bib31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.biopha.2017.06.036","article-title":"Inducible nitric oxide synthase: good or bad?","volume":"93","author":"Lind","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.niox.2021.08.006_bib32","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.ATV.0000172626.00296.ba","article-title":"Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction","volume":"25","author":"Gunnett","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2021.08.006_bib33","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.prostaglandins.2016.05.001","article-title":"Participation of oleic acid in the formation of the aortic aneurysm in Marfan syndrome patients","volume":"123","author":"Soto","year":"2016","journal-title":"Prostag. Other Lipid Mediat."},{"key":"10.1016\/j.niox.2021.08.006_bib34","first-page":"1329","article-title":"Preliminary analysis of the association of TRPV1 to the formation of marfan syndrome aneurysms","volume":"34","author":"Soto","year":"2019","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.niox.2021.08.006_bib35","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jtcvs.2007.12.063","article-title":"Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms","volume":"136","author":"He","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.niox.2021.08.006_bib36","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/CIRCULATIONAHA.105.601674","article-title":"Induction of macrophage chemotaxis by aortic extracts of the mgR Marfan mouse model and a GxxPG-containing fibrillin-1 fragment","volume":"114","author":"Guo","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2021.08.006_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032963","article-title":"Inflammation aggravates disease severity in Marfan syndrome patients","volume":"7","author":"Radonic","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.niox.2021.08.006_bib38","doi-asserted-by":"crossref","first-page":"C977","DOI":"10.1152\/ajpcell.00377.2009","article-title":"Microfibrils and fibrillin-1 induce integrin-mediated signaling, proliferation and migration in human endothelial cells","volume":"299","author":"Mariko","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.niox.2021.08.006_bib39","article-title":"Induction of macrophage chemotaxis by aortic extracts from patients with marfan syndrome is related to elastin binding protein","volume":"6","author":"Guo","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.niox.2021.08.006_bib40","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1038\/s41467-021-22933-3","article-title":"Aortic disease in Marfan syndrome is caused by overactivation of sGC-PRKG signaling by NO","volume":"12","author":"de la Fuente-Alonso","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.niox.2021.08.006_bib41","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/j.ajpath.2019.05.003","article-title":"Sildenafil prevents marfan-associated emphysema and early pulmonary artery dilation in mice","volume":"189","author":"White","year":"2019","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.niox.2021.08.006_bib42","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1152\/physrev.1995.75.3.519","article-title":"Flow-mediated endothelial mechanotransduction","volume":"75","author":"Davies","year":"1995","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.niox.2021.08.006_bib43","first-page":"H1145","article-title":"Flow-induced release of endothelium-derived relaxing factor","volume":"250","author":"Rubanyi","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.niox.2021.08.006_bib44","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0002-8703(00)90045-0","article-title":"Peripheral resistance vessel dysfunction in Marfan syndrome","volume":"139","author":"Nakamura","year":"2000","journal-title":"Am. Heart J."},{"key":"10.1016\/j.niox.2021.08.006_bib45","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00380-013-0393-3","article-title":"Impairment of flow-mediated dilation correlates with aortic dilation in patients with Marfan syndrome","volume":"29","author":"Takata","year":"2014","journal-title":"Heart Ves."},{"key":"10.1016\/j.niox.2021.08.006_bib46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3389\/fphys.2018.00965","article-title":"The evaluation of flow-mediated vasodilation in the brachial artery correlates with endothelial dysfunction evaluated by nitric oxide synthase metabolites in marfan syndrome patients","volume":"9","author":"Lomel\u00ed","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.niox.2021.08.006_bib47","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/01.HYP.0000239206.64270.5f","article-title":"Endothelial function is associated with pulse pressure, pulse wave velocity, and augmentation index in healthy humans","volume":"48","author":"McEniery","year":"2006","journal-title":"Hypertension (Dallas)"},{"key":"10.1016\/j.niox.2021.08.006_bib48","article-title":"Endothelial dysfunction and heart failure: a review of the existing bibliography with emphasis on flow mediated dilation","volume":"8","author":"Giannitsi","year":"2019","journal-title":"JRSM Cardiovasc. Dis."},{"key":"10.1016\/j.niox.2021.08.006_bib49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/mrm.24562","article-title":"Aortic wall shear stress in Marfan syndrome","volume":"70","author":"Geiger","year":"2013","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib50","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.bbrc.2019.03.083","article-title":"Rapamycin attenuates a murine model of thoracic aortic aneurysm by downregulating the miR-126\u20133p mediated activation of MAPK\/ERK signalling pathway","volume":"512","author":"Liu","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2021.08.006_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148012","article-title":"Loss of endothelial barrier in marfan mice (mgR\/mgR) results in severe inflammation after adenoviral gene therapy","volume":"11","author":"Seppelt","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.niox.2021.08.006_bib52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/10623329309102697","article-title":"Endothelial cell and platelet function in marfan's syndrome","volume":"1","author":"Bridges","year":"1993","journal-title":"Endothelium"},{"key":"10.1016\/j.niox.2021.08.006_bib53","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.ehj.2003.08.020","article-title":"Phenotypic variability of cardiovascular manifestations in Marfan Syndrome. Possible role of hyperhomocysteinemia and C677T MTHFR gene polymorphism","volume":"24","author":"Giustia","year":"2003","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2021.08.006_bib54","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1161\/01.ATV.0000189559.87328.e4","article-title":"Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation","volume":"25","author":"Jiang","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2021.08.006_bib55","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1476-5381.2009.00439.x","article-title":"Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome","volume":"156","author":"Syyong","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2021.08.006_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2012.09.016","article-title":"Selective loss of basal but not receptor-stimulated relaxation by endothelial nitric oxide synthase after isolation of the mouse aorta","volume":"696","author":"Van Langen","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.niox.2021.08.006_bib57","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0707181","article-title":"Endothelial dysfunction and compromised eNOS\/Akt signaling in the thoracic aorta during the progression of Marfan syndrome","volume":"150","author":"Chung","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2021.08.006_bib58","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.1476-5381.2009.00443.x","article-title":"Long-term effects of losartan on structure and function of the thoracic aorta in a mouse model of Marfan syndrome","volume":"58","author":"Yang","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2021.08.006_bib59","doi-asserted-by":"crossref","first-page":"101757","DOI":"10.1016\/j.redox.2020.101757","article-title":"Targeting feed-forward signaling of TGF\u03b2\/NOX4\/DHFR\/eNOS uncoupling\/TGF\u03b2 axis with anti-TGF\u03b2 and folic acid attenuates formation of aortic aneurysms: novel mechanisms and therapeutics","volume":"38","author":"Huang","year":"2021","journal-title":"Redox Biol."},{"author":"Sharma","key":"10.1016\/j.niox.2021.08.006_bib60"},{"issue":"3","key":"10.1016\/j.niox.2021.08.006_bib61","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajpath.2017.11.006","article-title":"Inhibition of marfan syndrome aortic root dilation by losartan: role of angiotensin II receptor type 1-independent activation of endothelial function","volume":"188","author":"Sellers","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.niox.2021.08.006_bib62","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1172\/JCI25426","article-title":"Anaphylactic shock depends on PI3K and eNOS-derived NO","volume":"116","author":"Cauwels","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.niox.2021.08.006_bib63","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jpeds.2014.07.008","article-title":"Collins 2nd, beta-Blockers and angiotensin converting enzyme inhibitors: comparison of effects on aortic growth in pediatric patients with Marfan syndrome","volume":"165","author":"Phomakay","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.niox.2021.08.006_bib64","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jpeds.2014.08.002","article-title":"What is the optimal medical therapy for Marfan syndrome?","volume":"165","author":"Pyeritz","year":"2014","journal-title":"J. Pediatr."},{"key":"10.1016\/j.niox.2021.08.006_bib65","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1017\/S1047951112001412","article-title":"A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome","volume":"23","author":"Thakur","year":"2013","journal-title":"Cardiol. Young"},{"key":"10.1016\/j.niox.2021.08.006_bib66","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.amjcard.2013.06.019","article-title":"Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome","volume":"112","author":"Pees","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib67","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/FJC.0000000000000560","article-title":"The effect of a nonpeptide angiotensin II type 2 receptor agonist, compound 21, on aortic aneurysm growth in a mouse model of marfan syndrome","volume":"71","author":"Verbrugghe","year":"2018","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.niox.2021.08.006_bib68","article-title":"Blood pressure-independent inhibition of Marfan aortic root widening by the angiotensin II receptor blocker valsartan","volume":"9","author":"Tehrani","year":"2021","journal-title":"Phys. Rep."},{"key":"10.1016\/j.niox.2021.08.006_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220903","article-title":"Angiotensin II receptor blocker losartan exacerbates muscle damage and exhibits weak blood pressure-lowering activity in a dysferlin-null model of Limb-Girdle muscular dystrophy type 2B","volume":"14","author":"White","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.niox.2021.08.006_bib70","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.120.051171","article-title":"Extracellular tuning of mitochondrial respiration leads to aortic aneurysm","volume":"143","author":"Oller","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2021.08.006_bib71","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1161\/CIRCULATIONAHA.104.509760","article-title":"Losartan metabolite EXP3179 activates Akt and endothelial nitric oxide synthase via vascular endothelial growth factor receptor-2 in endothelial cells: angiotensin II type 1 receptor-independent effects of EXP3179","volume":"112","author":"Watanabe","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2021.08.006_bib72","first-page":"703","article-title":"Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan","volume":"22","author":"Fujiwara","year":"2008","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib73","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nm1536","article-title":"Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states","volume":"13","author":"Cohn","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib74","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/S0140-6736(19)32518-8","article-title":"Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial","volume":"394","author":"Mullen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.niox.2021.08.006_bib75","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1056\/NEJM199405123301902","article-title":"Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome","volume":"330","author":"Shores","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib76","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/0002-9149(94)90762-5","article-title":"Effect of beta-adrenergic blockade on aortic root rate of dilation in the Marfan syndrome","volume":"74","author":"Salim","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib77","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpeds.2006.09.003","article-title":"Beta-blocker therapy does not alter the rate of aortic root dilation in pediatric patients with Marfan syndrome","volume":"150","author":"Selamet Tierney","year":"2007","journal-title":"J. Pediatr."},{"key":"10.1016\/j.niox.2021.08.006_bib78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9149(98)00315-4","article-title":"Changes in aortic distensibility and pulse wave velocity assessed with magnetic resonance imaging following beta-blocker therapy in the Marfan syndrome","volume":"82","author":"Groenink","year":"1998","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib79","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ijcard.2014.11.082","article-title":"A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes","volume":"179","author":"Sandor","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib80","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.amjhyper.2005.08.007","article-title":"Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity","volume":"19","author":"Dhakam","year":"2006","journal-title":"Am. J. Hypertens."},{"issue":"Suppl 3","key":"10.1016\/j.niox.2021.08.006_bib81","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/00005344-200112003-00003","article-title":"Nebivolol: endothelium-mediated vasodilating effect","volume":"38","author":"Ritter","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.niox.2021.08.006_bib82","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s11906-000-0061-8","article-title":"Antihypertensive drugs and reversing of endothelial dysfunction in hypertension","volume":"2","author":"Taddei","year":"2000","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.niox.2021.08.006_bib83","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11906-007-0050-2","article-title":"The vasodilatory beta-blockers","volume":"9","author":"Pedersen","year":"2007","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.niox.2021.08.006_bib84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2298\/VSP1202195K","article-title":"Should we prescribe \u201cvasodilating\u201d beta-blockers in Marfan syndrome to prevent aortic aneurysm and dissection?","volume":"69","author":"Kora\u0107evi\u0107","year":"2012","journal-title":"Vojnosanit. Pregl."},{"key":"10.1016\/j.niox.2021.08.006_bib85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ajh.2008.156","article-title":"\u03b2-Blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection","volume":"21","author":"Mahmud","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.niox.2021.08.006_bib86","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.acvd.2010.04.008","article-title":"Rationale and design of a randomized clinical trial (Marfan Sartan) of angiotensi II receptor blocker therapy versus placebo in individuals with Marfan syndrome","volume":"103","author":"Detaint","year":"2010","journal-title":"Arch. Cardiovasc. Dis."},{"key":"10.1016\/j.niox.2021.08.006_bib87","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib88","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mayocp.2012.11.005","article-title":"Losartan added to beta-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study","volume":"88","author":"Chiu","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.niox.2021.08.006_bib89","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1093\/eurheartj\/ehaa377","article-title":"Long-term clinical outcomes of losartan in patients with Marfan syndrome: follow-up of the multicentre randomized controlled COMPARE trial","volume":"41","author":"Van Andel","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.niox.2021.08.006_bib90","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jfma.2019.03.018","article-title":"The effects of losartan versus beta-blockers on cardiovascular protection in marfan syndrome: a systematic review and meta-analysis","volume":"119","author":"Kang","year":"2020","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.niox.2021.08.006_bib91","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41569-018-0065-1","article-title":"Exercise benefits in cardiovascular disease: beyond attenuation of traditional risk factors","volume":"15","author":"Fiuza-Luces","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib92","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006438","article-title":"Cardiovascular benefits of moderate exercise training in marfan syndrome: insights from an animal model","volume":"6","author":"Mas-Stachurska","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.niox.2021.08.006_bib93","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/bjsports-2014-306440rep","article-title":"Marfan syndrome, inherited aortopathies and exercise: what is the right answer?","volume":"50","author":"Cheng","year":"2016","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.niox.2021.08.006_bib94","first-page":"180","article-title":"Evaluation of collagen fibers, MMP2, MMP9, 8-OHdG and apoptosis in the aorta of ovariectomized LDL knockout mice submitted to aerobic exercise","volume":"112","author":"Maifrino","year":"2019","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.niox.2021.08.006_bib95","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.3389\/fphys.2019.01009","article-title":"Aerobic exercise training prevents perivascular adipose tissue-induced endothelial dysfunction in thoracic aorta of obese mice","volume":"10","author":"Sousa","year":"2019","journal-title":"Front. Physiol."},{"key":"10.1016\/j.niox.2021.08.006_bib96","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.tice.2019.01.005","article-title":"Protective effects of exercise on heart and aorta in high-fat diet-induced obese rats","volume":"57","author":"Acikel Elmas","year":"2019","journal-title":"Tissue Cell"},{"key":"10.1016\/j.niox.2021.08.006_bib97","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/157016111796197288","article-title":"Doxycycline inhibition of abdominal aortic aneurysm growth: a systematic review of the literature","volume":"9","author":"Dodd","year":"2011","journal-title":"Curr. Vasc. Pharmacol."},{"key":"10.1016\/j.niox.2021.08.006_bib98","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1001\/jama.2020.5230","article-title":"Effect of doxycycline on aneurysm growth among patients with small infrarenal abdominal aortic aneurysms: a randomized clinical trial","volume":"323","author":"Baxter","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.niox.2021.08.006_bib99","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jvs.2007.09.016","article-title":"Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome","volume":"47","author":"Xiong","year":"2008","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.niox.2021.08.006_bib100","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","article-title":"Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9","volume":"102","author":"Chung","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2021.08.006_bib101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-64071-8","article-title":"Characterization of doxycycline-mediated inhibition of Marfan syndrome-associated aortic dilation by multiphoton microscopy","volume":"10","author":"Tehrani","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.niox.2021.08.006_bib102","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nm948","article-title":"Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells","volume":"9","author":"Aicher","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib103","first-page":"124","article-title":"Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling","volume":"19","author":"Antoniades","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2021.08.006_bib104","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1161\/CIRCULATIONAHA.110.012187","article-title":"Pravastatin reduces marfan aortic dilation","volume":"124","author":"McLoughlin","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2021.08.006_bib105","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008543","article-title":"Statins reduce thoracic aortic aneurysm growth in marfan syndrome mice via inhibition of the ras-induced ERK (Extracellular signal-regulated kinase) signaling pathway","volume":"7","author":"Sato","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.niox.2021.08.006_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071523","article-title":"Resveratrol and its effects on the vascular system","volume":"20","author":"Breuss","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.niox.2021.08.006_bib107","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1161\/01.CIR.0000034445.31543.43","article-title":"Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells","volume":"106","author":"Leikert","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2021.08.006_bib108","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1161\/01.CIR.0000029925.18593.5C","article-title":"Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase","volume":"106","author":"Wallerath","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.niox.2021.08.006_bib109","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1161\/ATVBAHA.116.307841","article-title":"Resveratrol inhibits aortic root dilatation in the Fbn1 C1039G\/+ marfan mouse model","volume":"36","author":"Hibender","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2021.08.006_bib110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.freeradbiomed.2013.05.034","article-title":"Mechanosensitive microRNAs - role in endothelial responses to shear stress and redox state","volume":"64","author":"Marin","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib111","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1161\/01.ATV.0000256466.65450.ce","article-title":"KLF2 suppresses TGF-\u03b2 signaling in endothelium through induction of Smad7 and inhibition of AP-1","volume":"27","author":"Boon","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.niox.2021.08.006_bib112","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/CIRCRESAHA.116.310371","article-title":"The pathogenic transforming growth factor-\u03b2 overdrive hypothesis in aortic aneurysms and dissections: a mirage?","volume":"120","author":"Mallat","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.niox.2021.08.006_bib113","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.niox.2021.08.006_bib114","doi-asserted-by":"crossref","first-page":"815","DOI":"10.7326\/0003-4819-159-12-201312170-00007","article-title":"Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial","volume":"159","author":"Meijer","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.niox.2021.08.006_bib115","doi-asserted-by":"crossref","DOI":"10.1007\/s11136-018-1859-7","article-title":"Executive function and quality of life in individuals with Marfan syndrome","author":"Ratiu","year":"2018","journal-title":"Qual. Life Res."},{"key":"10.1016\/j.niox.2021.08.006_bib116","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.cjco.2020.12.018","article-title":"Aortic dimensions, biophysical properties, and plasma biomarkers in children and adults with marfan or loeys-dietz syndrome","volume":"3","author":"Cui","year":"2021","journal-title":"CJC Open"}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860321000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860321000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T18:07:24Z","timestamp":1761070044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860321000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":116,"alternative-id":["S1089860321000884"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2021.08.006","relation":{},"ISSN":["1089-8603"],"issn-type":[{"type":"print","value":"1089-8603"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nitric oxide in the Marfan vasculature: Friend or foe?","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2021.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}